Balchem Corp

BCPC

Equity

ISIN US0576652004 / Valor 910930

NASDAQ (2024-12-24)

USD 167.17+1.11%

Balchem Corp
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Balchem Corp is a diversified global company that operates across three main business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. With over 55 years of experience, the company has carved a niche in developing innovative solutions that cater to the health and nutritional needs of both humans and animals around the world. In the realm of Human Nutrition & Health, Balchem offers a range of products that contribute to the wellbeing of people. The Animal Nutrition & Health segment is recognized for being a global leader in choline production and encapsulation technology, offering a comprehensive portfolio of nutrition products for various types of animals, including ruminants, monogastrics, and companion animals. Additionally, the Specialty Products division focuses on the packaging and global distribution of select gases, as well as providing Metalosate® chelated minerals to the agricultural market worldwide. Balchem prides itself on delivering high-quality services and technologies that enable its customers to achieve success, thereby building a strong reputation for achieving results for all stakeholders involved.

Summarized from source with an LLMView SourceSector: Industrials

Net Sales Growth

In the third quarter of 2024, Balchem Corp reported net sales of $239.9 million, marking a 4.3% increase compared to the same quarter in the previous year. This growth reflects the company's strong performance across its various segments.

Record Earnings and EBITDA

Balchem Corp achieved net earnings of $33.8 million for the third quarter of 2024, representing a 16.4% increase from the prior year quarter. Additionally, the company reported a record adjusted EBITDA of $64.4 million, which is a 7.6% increase from the previous year.

Earnings Per Share

For the third quarter of 2024, Balchem Corp reported GAAP earnings per share of $1.03, up from $0.90 in the same quarter of the previous year. The company also achieved record adjusted earnings per share of $1.13, compared to $1.04 in the prior year quarter.

Cash Flow and Debt Repayment

Balchem Corp generated cash flows from operations amounting to $51.3 million in the third quarter of 2024, with a free cash flow of $42.2 million. The strong cash flow enabled the company to make repayments on its revolving debt of $39.6 million, reducing its net debt to $153.3 million.

Segment Performance

Balchem Corp's Human Nutrition and Health and Specialty Products segments both delivered strong sales and earnings growth in the third quarter of 2024. The company continues to innovate and expand its product offerings, contributing to its robust financial performance.

Summarized from source with an LLMView Source

Key figures

13.9%1Y

1.80%3Y

63.4%5Y

Performance

23.2%1Y

25.6%3Y

29.1%5Y

Volatility